Abstract
The herb Kalanchoe lanceolata, which is widely used in traditional medicine, has showed promise in treating a range of ailments. Despite its widespread usage in traditional medicine, the phytochemical contents of K. lanceolata are not well studied, particularly in terms of its potential involvement in diabetes management. In this study, the objective was to identify the phytochemical constituents of K. lanceolata and determine how they can help with diabetes management. The whole plant methanolic, ethyl acetate, and petroleum ether extracts were analysed with GC-MS to identify bioactive components. In this study, 63 compounds were identified, 27 of which possess bioactive properties. Acorenone B, columbin, phytol, astaxanthin, β-sitosterol, 2,4-di-tert-butylphenol, and caryophyllene oxide are significant compounds found to be present in K. lanceolata. In silico molecular docking studies predicted the antidiabetic and antibacterial properties of phytochemical compounds. These compounds show potential as antibacterial, antifungal and antidiabetic agents. This study stresses the significance of K. lanceolata bioactive components and sheds light on the therapeutic potential in diabetes control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Research in Pharmaceutical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
